Skip to main content
. 2014 Aug 14;10(5):2346–2350. doi: 10.3892/mmr.2014.2490

Figure 4.

Figure 4

Effects of metformin on SKOV3/DDP cisplatin-resistant ovarian cancer cell proliferation. SKOV3-DDP cells were treated with different concentrations of cisplatin and metformin for 72 h, followed by detection of cell proliferation levels using a bromodeoxyuridine (BrdU) ELISA kit. The results represent the means ± standard error of triplicate samples. Three independent experiments were performed. *P<0.05, one-way analysis of variance.